Report : Middle East & Africa Organ Preservation Solutions Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type [University of Wisconsin Solution (UW), Custodiol HTK, Perfadex, Hypothermosol, and Others], Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidneys, Liver, Lungs, Heart, and Others), and End User (Organ Transplant Centers, Hospitals, and Specialty Clinics)
At 6.5% CAGR, the Middle East & Africa Organ Preservation Solutions Market is speculated to be worth US$ 18.50 Million by 2028, says The Business Market Insights
According to the Business Market Insights’ research, the Middle East & Africa organ preservation solutions market was valued at US$ 13.53 Million in 2023 and is expected to reach US$ 18.50 Million by 2028, registering a CAGR of 6.5 % from 2023 to 2028. Rising need for organ transplantation and increasing prevalence of chronic diseases leading to kidney failure are the critical factors attributed to the Middle East & Africa organ preservation solutions market expansion.
The emerging regions such as the Middle East & Africa are growing significantly in the biotechnology and pharmaceutical sectors. The governments of countries in these regions are supporting through various initiatives, funding, programs, and conferences. For instance, there are three different and dominating models of practice in the developing countries. Saudi and Iranian, Saudi Arabia's concept entails the establishment of a national organ procurement center as a government body charged with supervising organ donation and transplantation. The Iranian approach is based on living donor kidney grafts. The growth of the organ transplantation solutions market is driven by economic and demographic development, a rise in healthcare expenditures, and improved public-private healthcare funding, among others.
Wockhardt is leading research-based global healthcare firm with relevance in pharma, biotechnology, and a chain of advanced super specialty hospitals. For 2021, the company has spent Rs 6,217.8 million on R&D, accounting for 66.9% of its turnover. They have spent 15% of their revenues compared to the previous year. Wockhardt's became the only company in the world to hold QIDP status for six antibiotics.
Emerging economies seek assistance from developed nations for advanced technologies and novel procedures. However, well-established players are turning to emerge nations for their expansions as these nations have enormous potential to offer market growth. Owing to the abovementioned factors, emerging regions will likely create growth opportunities for the organ preservation solutions market in the coming years.
On the contrary, expensive organ transplant surgeries hurdles the growth of Middle East & Africa organ preservation solutions market.
Based on type, the Middle East & Africa organ preservation solutions market is segmented into University of Wisconsin solution, custodiol HTK, perfadex, hypothermosol, and others. The University of Wisconsin solution segment held 41.2% share of Middle East & Africa organ preservation solutions market in 2023, amassing US$ 5.57 Million. It is projected to garner US$ 7.72 Million by 2028 to expand at 6.7% CAGR during 2023–2028.
Based on application, the Middle East & Africa organ preservation solutions market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held 45.7% share of Middle East & Africa organ preservation solutions market in 2023, amassing US$ 6.19 Million. It is projected to garner US$ 8.54 Million by 2028 to expand at 6.7% CAGR during 2023–2028.
Based on organ type, the Middle East & Africa organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held 59.2% share of Middle East & Africa organ preservation solutions market in 2023, amassing US$ 8.00 Million. It is projected to garner US$ 11.05 Million by 2028 to expand at 6.7% CAGR during 2023–2028.
Based on end user, the Middle East & Africa organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics, The organ transplant centers segment held 57.0% share of Middle East & Africa organ preservation solutions market in 2023, amassing US$ 7.71 Million. It is projected to garner US$ 10.67 Million by 2028 to expand at 6.7% CAGR during 2023–2028.
Based on country, the Middle East & Africa organ preservation solutions market has been categorized into the Saudi Arabia, South Africa, the UAE and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 46.2% share of Middle East & Africa organ preservation solutions market in 2023. It was assessed at US$ 6.24 Million in 2023 and is likely to hit US$ 8.46 Million by 2028, exhibiting a CAGR of 6.3% during the forecast period.
Key players dominating the Middle East & Africa organ preservation solutions market are Accord Healthcare; Dr. Franz Koehler Chemie GmbH; TransMedics; and XVIVO Perfusion. among others.
- In June 2019, TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com